The Diary of a CEODr. Nathan Bryan: Why losing nitric oxide drives disease
How daily mouthwash and common drugs silently shut down nitric oxide; erectile dysfunction shows up well before hypertension or memory loss.
CHAPTERS
- 0:00 – 3:30
Alzheimer’s, Chronic Disease, and an Overlooked Molecule
Bryan opens by claiming nitric oxide could eradicate Alzheimer’s and radically change global healthcare. He introduces nitric oxide as a signaling gas that controls blood flow, oxygen delivery, stem cell activity, and cellular energy, arguing its decline is the earliest step toward age‑related diseases.
- •Bold claim: NO has potential to cure or eradicate Alzheimer’s if applied early enough.
- •Nitric oxide defined as a gas signaling molecule regulating blood flow, oxygen delivery, and repair.
- •Loss of NO is framed as the earliest measurable event in age‑related chronic disease.
- •Common conditions linked: erectile dysfunction, diabetes, hypertension, cardiovascular disease.
- 3:30 – 9:00
Nitric Oxide 101: What It Is—and Isn’t
The discussion clarifies confusion between nitrous oxide (laughing gas) and nitric oxide and locates NO production in endothelial cells lining blood vessels. Bryan explains how aging reduces NO output and how this decline can be measured and potentially offset.
- •Distinction between nitrous oxide (N2O) and nitric oxide (NO).
- •Endothelium as the single‑cell layer that produces NO to control vascular tone and solute exchange.
- •Age‑related decline: 10–12% reduction in endothelial function per decade; 50% loss by ~40.
- •Biological age vs chronological age assessed via carotid thickness, flow‑mediated dilation, and epigenetic markers.
- 9:00 – 16:20
From Erectile Dysfunction to Hypertension: NO as Vascular Canary
Bryan positions erectile dysfunction as the earliest clinical sign of NO deficiency, shared by men and women, and explains how impaired vasodilation propagates into hypertension and cardiovascular disease. He highlights why many blood pressure drugs fail: they don’t restore NO.
- •ED in both sexes requires NO‑mediated penile/clitoral vasodilation; lack of NO equals ED.
- •ED reframed from ‘lifestyle disorder’ to early vascular disease and NO deficiency.
- •Mechanistic explanation: less NO → narrower vessels → same blood volume → higher pressure.
- •Half of hypertensive patients don’t respond to standard drugs because those drugs don’t fix NO.
- 16:20 – 23:00
Personal Eureka Moments: A Nobel Lecture and a Non‑Healing Wound
Bryan recounts how a Nobel laureate’s prediction about NO’s potential and his father’s catastrophic accident shaped his career. Struck by medicine’s failure to heal his paraplegic father’s chronic wounds, he developed a topical NO treatment that succeeded where standard care failed.
- •Influence of Louis Ignarro’s statement that restoring NO would ‘change the world.’
- •Bryan’s father: diabetic, paraplegic, hypertensive with a four‑year non‑healing wound.
- •Topical NO formulation healed the wound in six months by restoring blood flow and killing infection.
- •This experience convinced Bryan there “had to be a better way” than standard care.
- 23:00 – 27:20
Career and Credentials: From Academia to Translational NO Products
Bryan outlines his academic background in molecular and cellular physiology and his work with Nobel laureate Fred Murad. He describes leaving academia during COVID to focus on commercializing NO‑based technologies for chronic disease.
- •PhD in molecular and cellular physiology; faculty role in molecular medicine in Houston.
- •Over 100 peer‑reviewed publications and several medical textbooks on NO.
- •Departure from academia to build NO‑based diagnostics, topicals, and supplements.
- •Goal: move 25 years of bench research into accessible clinical and consumer solutions.
- 27:20 – 34:00
Is NO Loss Just ‘Normal Aging’—Or a Modifiable Process?
The conversation challenges whether NO decline is an unavoidable part of aging. Bryan argues aging is fundamentally failed cellular repair and that NO decline is modifiable; he cites young people with diseases of older age and older people with youthful vascular profiles.
- •Aging reframed as failure to repair and replace dysfunctional cells.
- •Evidence that NO decline can be accelerated (sick young adults) or delayed (fit older adults).
- •Bryan cites his own vascular age (36) at chronological age 51 via objective testing.
- •Multiple methods exist to quantify vascular and biological age (CIMT, FMD, methylation clocks).
- 34:00 – 41:20
NO, Metabolic Disease, and the Alzheimer’s Connection
Bryan links NO deficiency to metabolic syndrome and diabetes via impaired insulin signaling and expands on Alzheimer’s as a vascular and metabolic brain disease. He argues NO addresses all known physiological contributors to Alzheimer’s and outlines how clinical trials must be timed.
- •NO required for proper insulin signaling; absent NO → insulin resistance and diabetes.
- •Diabetes prevalence tied to widespread NO deficiency; 9/10 Americans deemed metabolically unfit.
- •Alzheimer’s described as vascular and metabolic: low brain blood flow, insulin resistance, oxidative stress, immune dysfunction, misfolded proteins.
- •Bryan claims NO improves cerebral blood flow, glucose uptake, inflammation, and oxidative stress, potentially preventing tau tangles and amyloid plaque.
- •Emphasis on intervening at mild cognitive impairment/early dementia stages to halt or reverse disease.
- 41:20 – 52:40
Systems Critique: Why Cures in Mice Don’t Reach Patients
Bryan sharply criticizes the medical–pharmaceutical complex, arguing that although many diseases are ‘cured’ in animals, translation fails due to uncontrolled human environments and perverse financial incentives. He contends the system is built on lifelong drug customers, not cures.
- •Animal studies succeed partly because researchers control diet, light, and drugs—unlike in humans.
- •Proposed ‘center of excellence’ model: integrate cardiology, neurology, GI, genetics to treat shared root causes.
- •Claim: major cancer centers and pharma have no economic incentive to cure chronic disease.
- •Medicine described as a trillion‑dollar customer‑retention business with polypharmacy as the norm.
- •Observation that discussions about weaning patients off drugs are rare and systemically discouraged.
- •Critique of regulatory capture: former FDA officials moving to high‑paying pharma roles.
- 52:40 – 1:00:40
Healthspan vs Lifespan: NO as the Molecule of Longevity
Shifting to longevity, Bryan distinguishes between living long and living well. He argues nitric oxide uniquely influences three core longevity levers—stem cells, telomeres, and mitochondrial function—justifying its label as a foundational longevity molecule.
- •Longevity framed as extending disease‑free healthspan, not just years lived.
- •Stem cells: NO mobilizes and guides pluripotent stem cells to repair tissues.
- •Telomeres: NO activates telomerase, preventing telomere shortening linked to doubled mortality risk.
- •Mitochondria: NO triggers mitochondrial biogenesis and efficiency, increasing ATP with less oxygen.
- •Bryan asserts no other molecule simultaneously and positively modulates all three.
- 1:00:40 – 1:05:50
Biohacking, Influencers, and Misconceptions Around Nitric Oxide
Bryan comments on high‑profile biohackers and influencers like Bryan Johnson, acknowledging some promote NO while others mistakenly label it toxic. He warns that non‑scientific voices can spread well‑intentioned but harmful advice and urges consumers to vet credentials and evidence.
- •Critique of biohacking culture driven by non‑scientists with large audiences.
- •Call to evaluate influencers’ scientific/medical background before following protocols.
- •Note that some popular biohackers incorrectly claim NO is a mitochondrial toxin.
- •Acknowledgment that as NO science is better translated, more people are embracing its benefits.
- 1:05:50 – 1:10:40
Can You Have Too Much NO? Safety and Toxicity
Bryan emphasizes that like water, NO can be overdosed but has clear toxicity signs. He outlines two main risks—dangerously low blood pressure and methemoglobinemia—and stresses the importance of dose control in product development to avoid undermining the field.
- •Dose makes the poison: excess NO can cause systemic vasodilation and hypotension.
- •Unsafe drops in blood pressure can lead to fainting, organ ischemia, and potentially death.
- •Methemoglobinemia: oxidation of hemoglobin iron reduces oxygen‑carrying capacity, causing cyanosis.
- •In practice, low blood pressure appears long before serious methemoglobinemia develops.
- 1:10:40 – 1:16:00
Telomeres, Cellular Replication, and NO’s Genomic Role
The discussion revisits telomeres and explains how NO influences telomerase at both gene expression and enzyme activity levels. Bryan connects telomere shortening to reduced lifespan and clarifies differing replication dynamics across tissues.
- •NO co‑localizes with estrogen receptors to enable telomerase gene transcription and activity.
- •Without NO, telomerase levels and function fall, accelerating telomere shortening.
- •Highly regenerative tissues (e.g., gut epithelium) differ from less regenerative neurons.
- •Shorter telomeres consistently correlate with shorter lifespan across populations.
- 1:16:00 – 1:27:10
Oral Microbiome, Fluoride, and the NO–Blood Pressure Axis
Bryan dives deep into the oral microbiome’s essential role in NO production and condemns routine use of fluoride and antiseptic mouthwashes. He explains that nitrate‑reducing oral bacteria convert dietary nitrate into bioactive NO, and killing them elevates blood pressure and systemic disease risk.
- •Human microbiome overview: diverse bacterial communities on skin, gut, vagina, and mouth support host health.
- •Humans lack nitrate‑reducing enzymes and are fully dependent on oral bacteria for this NO pathway.
- •Historical rationale for oral antiseptics: preventing heart attacks by reducing bacteremia from bleeding gums.
- •Modern data show mouthwash disrupts the microbiome, raising blood pressure and disease risk.
- •Bryan calls fluoride an antiseptic, thyroid toxin, and neurotoxin; questions its presence in toothpaste and water.
- •Study: 7 days of twice‑daily mouthwash in healthy subjects raised BP; one 21‑year‑old increased 26 mmHg.
- 1:27:10 – 1:33:20
Mouthwash, Diet, Exercise—and Losing the Benefits You Think You’re Gaining
Linking mechanisms to behavior, Bryan explains how mouthwash users lose the NO‑mediated cardiovascular benefits of both a plant‑rich diet and exercise. Without oral nitrate‑reducing bacteria, dietary nitrate is simply excreted and exercise‑induced NO is blunted.
- •Nitrate from leafy greens is concentrated in saliva and converted by oral bacteria to nitrite/NO.
- •Killing these bacteria means nitrate is recirculated and excreted, yielding no NO‑related benefit.
- •Dietary blood‑pressure‑lowering effects of plant‑based diets depend on intact oral microbiome.
- •Mouthwash users lose the cardioprotective benefits of exercise, per published data.
- •Two‑thirds of Americans use mouthwash and two‑thirds have elevated blood pressure—parallels highlighted.
- 1:33:20 – 1:43:20
Oral Infections, Dentistry, and Cancer Correlations
Bryan connects poor oral health, chronic dental infections, and cancer, especially solid tumors. While cautious about causality, he notes that nearly all late‑stage cancer patients he sees have significant oral issues and references large epidemiologic studies linking oral bacteria to cancer risk.
- •High prevalence of dental infections (root canals, cavitations) in solid tumor cancer patients Bryan sees.
- •Claim: 100% of his advanced solid‑tumor patients have dental infections when evaluated.
- •Discussion of meridians in Chinese/Ayurvedic medicine linking each tooth to organs; teeth as ‘circuit breakers.’
- •Root canals described as leaving dead, infection‑prone tissue in the body; systemic antibiotics can’t reach them.
- •NYU cohort: oral bacteria species associated with ~50% increased risk of head and neck cancers.
- •Bryan advises terminal patients not ready for hospice to see a dentist as a first step.
- 1:43:20 – 1:52:40
Improving Oral NO Pathways: What Not to Do—and What to Add
Bryan provides practical guidance for supporting NO via oral health. He stresses eliminating fluoride and antiseptic rinses, using non‑fluoridated toothpaste, tongue scraping correctly, and maintaining professional dental care without fluoride treatments.
- •Primary recommendation: stop fluoride toothpaste and fluoridated rinses; use non‑fluoridated alternatives.
- •Fluoride labeled as offering ‘no benefit and all risk’ according to toxicology data he cites.
- •Toothpaste warning: pea‑sized recommendation vs common overuse vastly increases fluoride exposure.
- •Tongue scraping shown to increase oral microbiome diversity and improve oral health.
- •Big caution: tongue scraping plus antiseptic mouthwash is worst‑case—opens niches then kills bacteria deeply.
- •Regular dental hygiene visits are encouraged, but without fluoride rinses.
- 1:52:40 – 2:01:00
Hormones, Exercise, Mouth Breathing, and the NO Feedback Loops
The conversation broadens to how sex hormones, vitamin D, and breathing patterns modulate NO. Bryan explains nasal breathing’s role in NO generation and warns that chronic mouth breathing and anatomical airway issues can devastate both oral microbiome and airway NO.
- •Testosterone (in men) and estrogen (in women) stimulate endothelial NO synthase when the enzyme is intact.
- •Exercise activates NO production, but its benefits are nullified if oral pathways are destroyed by mouthwash.
- •Mouth breathing bypasses sinus NO production and changes oral pH/oxygenation, harming microbiota.
- •Nasal breathing and mouth taping can be beneficial but only if airways are structurally open.
- •Bryan advises airway imaging before intensive mouth‑taping practices.
- 2:01:00 – 2:10:20
Diet, Sugar, and Why ‘What Not to Eat’ Matters Most
Returning to diet, Bryan prioritizes avoiding sugar and high‑glycemic foods over chasing specific ‘NO superfoods.’ He explains how glucose glycates and disables key enzymes, including NO synthase, and how this underpins the vascular complications of diabetes.
- •Sugar described as a toxin; glucose likened to ‘glue’ that sticks to proteins and enzymes.
- •Glycation of hemoglobin (HbA1c) as a marker of long‑term glucose control and diabetes.
- •Glycation of NO synthase locks it into non‑functional conformations, reducing NO.
- •Diabetic complications—retinopathy, neuropathy, non‑healing wounds—tied to profound NO deficiency.
- •Bryan favors balanced diet, high‑quality protein and fats, minimal carbs/sugar; views keto/vegan benefits as largely sugar elimination.
- 2:10:20 – 2:19:40
Beetroot, Nitrate, and Why Most ‘NO Boosters’ Don’t Deliver
Bryan discusses beetroot’s reputation as an NO booster and explains why many commercial beet products fail. While historically powerful, modern beets are nutrient‑depleted, and desiccated powders often lack active nitrate, leading him to call them ‘dead beets.’
- •2012 London Olympics popularized beet juice for performance via NO mechanisms.
- •Athletes needed liters of beet juice, causing GI distress and misinterpreted red urine/stools.
- •Analysis of commercial beet powders showed little or no nitrate/nitrite—no meaningful NO effect.
- •His lab used many beet products as placebos in trials because they had no measurable NO impact.
- •Historical note: ancient warriors likely drank beet juice, not wine, pre‑battle for performance.
- 2:19:40 – 2:26:40
Antacids, PPIs, and the Hidden Cost of Killing Stomach Acid
Bryan warns that chronic use of potent antacids and proton pump inhibitors impairs both nutrient absorption and NO generation in the stomach. He differentiates between occasional buffering (e.g., Tums) and long‑term acid suppression, which he sees as biochemically disastrous.
- •Stomach acid is essential for protein digestion and absorption of B‑vitamins, minerals (Mg, Fe, I, Se, Cr).
- •PPIs (e.g., omeprazole, pantoprazole, Nexium) now widely available OTC, not just by prescription.
- •Suppressing acid interferes with conversion of nitrite to NO in the acidic stomach.
- •Contrast between mild buffers (Tums, bicarbonate) and enzyme‑blocking PPIs.
- •High prevalence of magnesium and iodine deficiency in Americans attributed partly to acid suppression.
- 2:26:40 – 2:35:00
Breath, Humming, and Light: Non‑Dietary Ways to Boost NO
The dialogue explores non‑nutritional strategies for enhancing NO, including nasal breathing, humming, sunlight, and red/infrared light. Bryan notes these only work if NO synthase is still functional and the microbiome is intact.
- •Nasal breathing activates NO synthase in sinus epithelium; NO then dilates bronchial and pulmonary vessels.
- •Humming at resonant frequencies (e.g., ‘om’) increases NO in exhaled breath; frequency depends on sinus volume.
- •Elderly with non‑functional NO synthase don’t show NO increases from breathing exercises alone.
- •UV and red/infrared light can release protein‑bound NO and stimulate mitochondrial biogenesis.
- •Bryan personally uses red‑light beds and infrared saunas daily; warns against overuse of high‑SPF sunscreens with harmful chemicals.
- 2:35:00
Summing Up: The Future of NO‑Centered Medicine and Personal Trade‑offs
In closing, Bryan reiterates his conviction that future medicine will rely heavily on NO‑based technologies, while stressing that pills cannot fully compensate for harmful lifestyles. He also reflects on personal balance, acknowledging sacrifices in family time made in pursuit of scientific impact.
- •Bryan insists the future of healthcare will depend on NO diagnostics and therapeutics.
- •He stresses behavior change (diet, movement, oral care) remains essential alongside NO products.
- •Admits compliance and habit change are the biggest barriers to better health outcomes.
- •Personal reflection on work–life balance, parenting, and the inevitability of trade‑offs.
- •Resources shared: his book, YouTube channel, social media, and N1O1.com for NO‑releasing products.
